The glycosylation of airway mucins in cystic fibrosis and its relationship with lung infection by Pseudomonas aeruginosa
Roussel, P.; Lamblin, Gève.
Advances in Experimental Medicine and Biology 535: 17-32
2003
ISSN/ISBN: 0065-2598 PMID: 14714886 Document Number: 562687
Document emailed within 1 workday
Related Documents
Pier, G.B. 1997: Rationale for development of immunotherapies that target mucoid Pseudomonas aeruginosa infection in cystic fibrosis patients Behring Institute Mitteilungen 98: 350-360Giordano, A.; Magni, A.; Graziani, C.; Sessa, R.; Quattrucci, S.; Cipriani, P. 2001: AP-PCR typing of Pseudomonas aeruginosa isolated from patients with cystic fibrosis New Microbiologica 24(2): 157-163
Yagci, A.; Ciragil, P.; Over, U.; Sener, B.; Erturan, Z.; Soyletir, G. 2003: Typing of Pseudomonas aeruginosa strains in Turkish cystic fibrosis patients New Microbiologica 26(1): 109-114
Bustamante, A.E.; Mercado-Longoria, R.; Tijerina-Menchaca, R.; Mas-Treviño, M.; Torres-Rodríguez, J.án.N. 2014: Impact of eradication of Pseudomonas aeruginosa on survival in Mexican patients with cystic fibrosis Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 66(4): 307-313
Ortiz-Herrera, M.; Gerónimo-Gallegos, A.; Cuevas-Schacht, F.; Pérez-Fernández, L.; Coria-Jiménez, R. 2004: RAPD-PCR characterization of Pseudomonas aeruginosa strains obtained from cystic fibrosis patients Salud Publica de Mexico 46(2): 149-157
Cryz, S.J.; Lang, A.; Rüdeberg, A.; Wedgwood, J.; Que, J.U.; Fürer, E.; Schaad, U. 1997: Immunization of cystic fibrosis patients with a Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine Behring Institute Mitteilungen 1997(98): 345-349
Møller, N.E.; Eriksen, K.R.; Feddersen, C.; Flensborg, E.W.; Høiby, N.; Norn, S.; Rosendal, K.; Schiøtz, P.O.; Skov, P.S. 1982: Chemotherapy against Pseudomonas aeruginosa in cystic fibrosis. a study of carbenicillin, azlocillin or piperacillin in combination with tobramycin European Journal of Respiratory Diseases 63(2): 130-139
Quentin, R.; Bollet, C.; Dayan, A.; Martin, C.; Goudeau, A.; De Micco, P. 1993: Pseudomonas aeruginosa and cystic fibrosis: intrastrain variability in relation to intensity of immune response and clinical outcome New Microbiologica 16(2): 185-188
Vranes, J.; Tjesić-Drinković, D.; Zulj, I.; Kruzić, V.; Turković, B.; Marić, S. 2004: Adherence ability of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis to two different epithelial cell lines Collegium Antropologicum 28(2): 675-680
Ciofu, O.; Pressler, T.; Pandey, J.P.; Høiby, N. 1997: The influence of allotypes on the IgG subclass response to chromosomal beta-lactamase of Pseudomonas aeruginosa in cystic fibrosis patients Clinical and Experimental Immunology 108(1): 88-94
Pier, G.B.; Elcock, M.E. 1984: Nonspecific immunoglobulin synthesis and elevated IgG levels in rabbits immunized with mucoid exopolysaccharide from cystic fibrosis isolates of Pseudomonas aeruginosa Journal of Immunology 133(2): 734-739
Shigeta, S.; Goto, S.; Ishida, N. 1971: Pseudomonas aeruginosa infection in the hospital environment. 2. Pigment production and serotype of Pseudomonas aeruginosa isolated from clinical specimens Rinsho Byori. Japanese Journal of Clinical Pathology 19(1): 77-80
Vetkova, L.G.; Zaĭtsev, L.G.; Khasman, E.L.; Radkevich, S.A.; Moroz, A.F. 1986: Protective effect of a corpuscular polyvalent Pseudomonas aeruginosa vaccine in generalized chronic Pseudomonas aeruginosa infection in mice with cyclophosphamide-induced leukopenia Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 3: 14-18
Moore, J.E.; Rao, J.R. 2013: Efficacy of the biocide Steri-7 against the common Gram-negative bacterial pathogens (Burkholderia cenocepacia, Burkholderia gladioli, Burkholderia multivorans, Pseudomonas aeruginosa and Stenotrophomonas maltophilia) associated with cystic fibrosis (CF) British Journal of Biomedical Science 70(2): 80-81
Desai, V.C.; Shankar, V.; de la Rocha, S.R.; Sachdev, G.P. 1993: Peptide mapping reveals differences in the non-glycosylated domains of cystic fibrosis and normal tracheobronchial mucins Indian Journal of Biochemistry and Biophysics 30(6): 382-388
Lamblin, G.; Lhermitte, M.; Lafitte, J.J.; Filliat, M.; Degand, P.; Roussel, P. 1977: Comparative study of bronchial mucins isolated from the sputum of patients suffering from cystic fibrosis or other chronic bronchial diseases Bulletin Europeen de Physiopathologie Respiratoire 13(1): 175-190
Palkina, N.A.; Bulk, V.F.; Zhvanetskaia, M.I.; Stakislavskiĭ, E.S.; Kolker, I.I. 1978: Immunological study of cellular components of Pseudomonas aeruginosa. IV. Fractionation of Pseudomonas aeruginosa mucus by diafiltration and biological properties of isolated fractions Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 6: 50-55
Habboushe, C.; Iacocca, V.; Braddock, L.; Barbero, G. 1971: Pseudomonas agglutinins in patients with cystic fibrosis Pediatrics 48(6): 973-974
Featherby, E.A.; Weng, T.R.; Levison, H. 1970: The effect of isoproterenol on airway obstruction in cystic fibrosis Canadian Medical Association Journal 102(8): 835-838
Elvira, J.; López-Suárez, A.; Clavo, A.; Piña, J.M.; Segura, E.; Pérez-Guzmán, E.; Girón, J.A. 1998: Infection by Pseudomonas aeruginosa in patients with human immunodeficiency virus infection. Descriptive study of 35 cases Enfermedades Infecciosas y Microbiologia Clinica 16(7): 322-327